RE: Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition

首页> 外文期刊>Journal of the National Cancer Institute >RE: Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition

【24h】

RE: Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition

机译：Re：通用肿瘤DNA BRCA1 / 2卵巢癌试验：预筛选Parpi治疗和遗传易感性

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Journal of the National Cancer Institute》 |2020年第4期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition [J] . Vos Janet R., Fakkert Ingrid E., de Hullu Joanne A., Journal of the National Cancer Institute . 2020,第2期

机译：通用肿瘤DNA BRCA1 / 2卵巢癌试验：预筛选PARPI治疗和遗传易感性
2. RE: Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition [J] . Journal of the National Cancer Institute . 2020,第4期

机译：Re：通用肿瘤DNA BRCA1 / 2卵巢癌试验：预筛选Parpi治疗和遗传易感性
3. RE: Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition Response [J] . Journal of the National Cancer Institute . 2020,第4期

机译：Re：卵巢癌的通用肿瘤DNA BRCA1 / 2试验：预筛选Parpi治疗和遗传易感性反应
4. Discovery of altered metabolic pathways in PARPi-resistant ovarian cancer [C] . Chandra Shekar R Ambati, Sachin Gupta, Sajna A Vithayathil, ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：在耐药卵巢癌中发现改变的代谢途径
5. Dolo?anje Mutacij v Genih BRCA1/2 Iz citolo?kega Materiala Pri Raku jaj?nikov, Jajcevodov in Primarnem Peritonealnem Seroznem Karcinomu =BRCA1/2 mutation testing from cytological samples in patients with ovarian, tubal and primary peritoneal serous cancer [D] . Gornjec, Andreja. 2020

机译：从自我癌症中确定基因Krca1 / 2中的突变吗？
6. RE: Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition [O] . Federica Tomao, Pierluigi Benedetti Panici, Silverio Tomao -1

机译：RE：卵巢癌通用肿瘤DNA BRCA1 / 2测试：PARPi治疗的预筛选和遗传易感性
7. A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment [O] . Erica M. Bednar, Holly D. Oakley, Charlotte C. Sun, 2017

机译：高档，非粘液上皮性卵巢癌患者的普遍遗传检测倡议及癌症治疗的影响

RE: Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition

著录项

引文网络

相似文献

相关主题

期刊订阅